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ABSTRACT
Objective: During laparoscopic surgeries, pneumoperitoneum can lead to various pathophysiologic changes in the cardiovascular system resulting in 
hypertension and tachycardia. Search for ideal drug to prevent this hemodynamic response goes on. The aim of our study was to evaluate the effect of 
orally administered moxonidine in attenuating the hemodynamic responses that occur during the laparoscopic surgeries.
Methods: A total of 50 adult acetylsalicylic acid I and II patients scheduled for elective laparoscopic surgeries were selected for this prospective 
randomized double-blinded study. They were randomly allocated into two groups: moxonidine group (M) and placebo group (P). M group received 
oral moxonidine 0.3 mg at 8 pm on the day before surgery and at 8 am on the day of surgery. P group received a placebo at the same timing as that of 
the M group.
Results: Following pneumoperitoneum rise in systolic blood pressure (SBP), diastolic BP (DBP), mean arterial pressure (MAP), and heart rate (HR) 
was higher in P group in comparison to M group which was statistically significant.
Conclusion: Significant rise in HR, SBP, DBP, and mean BP was noted in the P group in comparison to moxonidine group. Moxonidine provided better 
perioperative hemodynamic stability in patients undergoing laparoscopic surgeries.
Keywords: Moxonidine, Stress response, Laparoscopic.
INTRODUCTION
Laparoscopic surgeries are the most commonly performed surgeries in 
general surgery. Overall, complication rate is <1.5%, and the mortality 
rate is 3.3 times greater in laparoscopic surgeries mainly due to 
pneumoperitoneum, compared to invasive surgeries [1]. Laparoscopic 
surgeries require pneumoperitoneum for which general anesthesia with 
endotracheal intubation and intermittent positive pressure ventilation 
is required. The pneumoperitoneum created for laparoscopy produces 
complex physiologic changes that can make anesthetic management 
more difficult [2]. The pathophysiologic changes resulting from 
pneumoperitoneum are directly related to clinical outcome. These 
changes include increase in the heart rate (HR), increase in mean arterial 
pressure (MAP) and decrease in cardiac output due to increase in systemic 
vascular resistance (SVR) resulting in reduced tissue perfusion. Various 
techniques and pharmacological agents have been used to counteract 
these detrimental effects of pneumoperitoneum. These changes are 
tolerated in ASA  I and II patients but it can be detrimental in elderly 
and ASA III and more grade patients particularly with compromised 
cardiovascular system. Various techniques and pharmacological agents 
have been used to counteract these life-threatening complications 
of pneumoperitoneum. These included gasless laparoscopy, use of 
β-adrenergic blockers, nitroglycerine, calcium channel blockers, and α-2 
agonists such as clonidine and dexmedetomidine but none was found to 
be ideal in completely reducing the side effects of pneumoperitoneum [3].
Moxonidine, a centrally acting antihypertensive drug has a weak 
affinity for the α2-adrenoceptor and is generally described as a selective 
I1-imidazoline receptor (I1R) agonist that lowers blood pressure (BP) by 
decreasing sympathetic activity within the central nervous system [4]. It 
acts on the rostral ventrolateral medulla and decrease the sympathetic 
nervous system activity as measured by serum norepinephrine, and 
plasma renin activity [5]. Various studies have shown that moxonidine 
reduces arterial pressure by lowering SVR while sparing HR, cardiac 
output, and stroke volume. In this study, orally administered moxonidine 
was evaluated for its impact on hemodynamic response that occurs 
during pneumoperitoneum in laparoscopic surgeries.
METHODS
After approval of the Institutional Ethics Committee and written 
informed consent, 70 patients, scheduled for elective laparoscopic 
surgeries under general anesthesia were enrolled for this double-blind 
prospective randomized study. Group M: Received moxonidine 0.3 mg 
at 8 pm the day before surgery and at 8 am on the day of surgery. 
Group P: Received placebo at 8 pm on the day before surgery and at 
8 am on the day of surgery. 70 healthy adult patients of ASA physical 
status I and II of either sex aged 20 to 60 years and weighing 50 to 
90 Kg were included in this study. Patients with hypertension, history 
of cardiac, pulmonary, hepatic or renal disease, psychiatric disorder, 
body mass index >30, and patients with difficult airway were excluded 
from this study. Routine investigations such as hemogram, complete 
blood analysis, liver function tests, serum electrolytes, serum protein, 
X-ray chest, and preoperative electrocardiogram were done and were 
analyzed. Patients were kept nil orally for 6 hrs preoperatively. They 
were randomly assigned to one of the two groups to receive either 
moxonidine 0.3 mg or placebo at 8 pm on the day before surgery and at 8 
am on the day of surgery. Infusion of ringer lactate solution was started 
after intravenous cannulation. The patients were premedicated with 
fentanyl (2 µg/kg), glycopyrrolate (0.004-0.006 mg/kg), and midazolam 
(0.03-0.05 mg/kg) 30 minutes before induction. After shifting to the 
operation theater, the patients were connected to noninvasive BP 
monitor, pulse oximeter, capnograph and electrocardiograph, and 
baseline parameters were recorded. All patients were preoxygenated 
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with 100% oxygen for 3 minutes. Induction of anesthesia was 
done with propofol (2 mg/kg), and intubation was facilitated using 
vecuronium bromide (0.08-0.12 mg/Kg). Anesthesia was maintained 
with vecuronium bromide (0.02 mg/Kg) and intermittent positive 
pressure ventilation with nitrous oxide and oxygen in the ratio of 2:1 
with 0.6% isoflurane. Pneumoperitoneum was created and maintained 
by insufflations of carbon dioxide.
The table was tilted depending on the requirement of surgery. 
Intraabdominal pressure was maintained between 12-15 mm Hg 
during the surgery. Throughout the study period, all the parameters 
selected (HR, systolic BP [SBP], diastolic BP [DBP], MAP SpO2, and 
ETCO2) were recorded. Any change in hemodynamic variables more 
than 20% on either side of baseline was considered significant. Any 
increase in MAP up to 20% from baseline was treated by increasing 
the concentration of isoflurane to a maximum 2% or nitroglycerine 
infusion so as to maintain the MAP within 20% of baseline. Time 
duration from creation of pneumoperitoneum to the release of 
pneumoperitoneum was taken as duration of pneumoperitoneum. 
At the end of surgery, neuromuscular blockade was reversed with IV 
neostigmine 60 µg/kg and glycopyrrolate 10 µg/kg. After extubation, 
the patients were transferred to postanesthesia care unit. All patients 
were assessed for changes in hemodynamic parameters (HR, SBP, DBP, 
and MAP) before premedication and induction, after laryngoscopy 
and intubation. After pneumoperitoneum, same parameters were 
recorded at 5 minutes interval for 10 minutes, followed by every 
10 minutes for 40 minutes, then thereafter every 20 minutes until end 
of pneumoperitoneum. The results were expressed as mean±standard 
deviation which was calculated for all quantitative variables using 
SPSS statistical software version 16. Comparison between two groups 
was done using Student’s unpaired t-test. p<0.05 was considered 
statistically significant.
Observation
There were no significant differences were found with respect to age, 
weight, and gender, ASA status and duration of surgery (Table 1).
The mean pulse rate at 5 minutes, 10 minutes, 20 minutes, 30 minutes, 
40 minutes, and 60 minutes after pneumoperitoneum is lower in 
moxonidine group than Placebo group. The results were statistically 
significant (p<0.05) (Graph 1).
Graph 2 compares the mean SBP between moxonidine and P group 
at various time intervals during the surgery. Mean SBP was lower 
in M group compared to P group which was statistically significant 
(p<0.05).
Graph 3 compares the mean diastolic BP between moxonidine and 
P group at various intervals during the surgery. Mean DBP was lower 
in M group compared to P group which was statistically significant 
(p<0.05).
Graph 4 compares the mean arterial BP recorded at various intervals 
during the surgery. MAP was lower in M group compared to P group at 
different time interval which was statistically significant (p<0.05).
DISCUSSION
Pneumoperitoneum during the laparoscopic surgery can lead to 
significant hemodynamic changes such as an increase in MAP and 
SVR and a decrease in cardiac output [6]. These hemodynamic 
responses can result in complications such as myocardial ischemia, 
cerebral hemorrhage, and difficulty in mechanical ventilation of 
patients. Moxonidine is a centrally acting antihypertensive drug that 
reduces arterial BP by inhibiting central sympathetic activity [7]. Its 
chemical formula is 4-chloro-N-(imidazolidin-2-ylidene)-6-methoxy-
2-methyl-5-pyrimidinamine. Its empirical formula is C9H12CIN5O 
and its molecular weight is 241.68 [8]. Moxonidine is an imidazoline 
compound which acts on I1R in the central nervous system to reduce 
sympathetic activity and BP. Farsang, his review of moxonidine, 
concluded that it suppresses sympathetic tone and effectively reduces 
BP for at least 24 hrs, and therefore, it can be administered once 
daily [9]. Joris et al. investigated hemodynamic changes induced by 
carbon dioxide insufflations in pneumoperitoneum and concluded 
that vasopressin and catecholamines are probable mediators in 
increasing the SVR observed during pneumoperitoneum. They 
concluded that clonidine can modulate the hemodynamic changes 
due to pneumoperitoneum [10]. Koivusalo et al., in their study, have 
shown that postoperative recovery after laparoscopic cholecystectomy 
was faster and uneventful when carbon dioxide was not used for 
Graph 2: Changes in mean systolic blood pressure
Graph 3: Changes in mean diastolic blood pressure
Graph 4: Changes in mean arterial pressure
Graph 1: Changes in mean pulse rate
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pneumoperitoneum. They suggested that mechanical abdominal lift 
method without carbon dioxide insufflations is better for laparoscopic 
cholecystectomy may be the method of choice while considering 
laparoscopic cholecystectomy [11]. Fenton et al., in their review, 
observed that moxonidine acts centrally to reduce central and peripheral 
sympathetic activity, thus decreasing peripheral vascular resistance. 
In patients with mild to moderate hypertension, moxonidine reduces 
BP as effectively as most first-line antihypertensives. It improves 
the clinical and metabolic profile in patients with hypertension and 
diabetes mellitus [12]. Malek et al. evaluated the effect of moxonidine 
on the attenuation of hemodynamic response during laparoscopic 
cholecystectomy in comparison with clonidine. They had concluded 
that administration of clonidine in premedication before laparoscopic 
cholecystectomy provides better results; compared to moxonidine [13]. 
Sung et al. studied the effect of oral clonidine as premedication on 
perioperative hemodynamic response and post-operative analgesic 
requirement for patients undergoing laparoscopic cholecystectomy 
and observed that oral clonidine premedication helped to provide 
perioperative hemodynamic stability. It reduced the use of isoflurane 
and requirement of post-operative analgesia [14]. Das et al. studied 
the effect of clonidine premedication on hemodynamic changes during 
laparoscopic cholecystectomy. They concluded that clonidine is safe 
and effective in providing stable hemodynamics. It protects against 
stress response due to pneumoperitoneum in patients undergoing 
laparoscopic cholecystectomy [15].
Bansal and Hooda concluded in his review of newer drugs in 
anesthesia that clonidine is not only a good antihypertensive but also 
it provides perioperative hemodynamic stability and obtunds pressure 
response to endotracheal intubation [16]. Banday and Sameer, in his 
article, reviewed effect of gabapentin and opined that like clonidine, 
gabapentin also attenuates hemodynamic stress response to direct 
laryngoscopy and tracheal intubation [17]. In our study, the overall 
hemodynamic profile was stable in the moxonidine group when 
compared to the P group. The fluctuations in mean pulse rate, SBP, 
DBP, and MAP were significant throughout the intraoperative period 
in the moxonidine group compared to P group. The results obtained 
in our study are consistent with the previous studies which used 
clonidine and dexmedetomidine in reducing stress response due to 
pneumoperitoneum. Moxonidine has a favorable effect on the clinical 
and metabolic profile in the body. Hence, it can be used in patients 
having some derangement in the metabolic profile with regard to blood 
sugar levels, lipid profile, etc. Moxonidine may have an edge over other 
centrally acting antihypertensive like clonidine and dexmedetomidine 
due to their side effects like bradycardia and sedation.
CONCLUSION
The use of moxonidine in laparoscopic surgeries is a promising 
approach in attenuating the hemodynamic response during the 
intraoperative period. It not only prevents stress response due to 
endotracheal intubation and extubation but also facilitates smooth 
recovery from anesthesia.
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Table 1: Demographic profile
Parameter Moxonidine Placebo p
Age 41.24±6.17 41±7.35 0.9
Sex (M/F) 12:13 11:14 0.8
Weight 66.32±6.38 66.80±6.08 0.78
ASA status (I/II) 29/6 30/5 0.7
Duration of surgery 45.5±5.80 46.9±4.7 0.82
ASA: Acetylsalicylic acid
